The information contained within this web site is intended and appropriate for U.S. residents only


We love hearing from our customers about how Denavir® has made a difference in their lives. Some of our favorites are posted below. The entries have been edited where necessary, and actual names have been withheld to protect our customers' privacy.

Happily Ever After
When Nothing Else Works

Fun in the Sun?

Denavir® was generally well tolerated in all clinical trials -- the most frequently reported adverse events with Denavir® and placebo in the pivotal trials, respectively, were headache (5.3% vs 5.8%) and application site reaction (1.3% vs 1.8%). In the most recent trial the adverse events were no different.
 
 





Copyright 2003 © Novartis Consumer Health Inc. All Rights Reserved. Your use of this website is subject to the terms of our Legal Statement and Privacy Policy. The product information contained in this site is intended for residents of the United States only. For more information on Novartis and other Novartis products, see Novartis.com.


Last Updated: Wednesday, November 05, 2003